title: Left ventricular hypertrophy and arrhythmogenesis.
abstract: Left ventricular hypertrophy (LVH) poses an independent risk of increased morbidity and mortality, including atrial arrhythmias, ventricular arrhythmias, and sudden cardiac death. The most common causes of LVH are hypertension and valvular heart disease. Electrocardiography and echocardiography are the first steps in the diagnosis and evaluation of therapy in patients with LVH. Cardiac MRI is the gold standard in diagnosis and assessment of response to therapy. Management of LVH should be based on etiology, evidence, and guideline adherence. Timely and optimal management of the underlying cause of LVH results in improvement (regression) of LVH and its related complications.
authors.affiliation: Department of Cardiovascular Services, O'Connor Hospital, San Jose, CA 95128, USA; Heart and Rhythm Medical Group, 105 North Bascom Avenue, San Jose, CA 92128, USA. Electronic address: mohammad.shenasa@gmail.com.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Shenasa
authors.affiliation: Department of Cardiovascular Services, O'Connor Hospital, San Jose, CA 95128, USA; Heart and Rhythm Medical Group, 105 North Bascom Avenue, San Jose, CA 92128, USA.
authors.forename: Hossein
authors.initials: H
authors.lastname: Shenasa
authors.affiliation: State University of New York, Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA; Cardiology Division, New York Harbor VA Healthcare System, 800 Poly Place, Brooklyn, NY 11209, USA.
authors.forename: Nabil
authors.initials: N
authors.lastname: El-Sherif
mesh_terms: D001145:Arrhythmias, Cardiac; D006801:Humans; D006973:Hypertension; D017379:Hypertrophy, Left Ventricular; D016171:Torsades de Pointes
keywords: Arrhythmogenesis; Atrial fibrillation; Hypertension; Hypertensive heart disease; Left ventricular hypertrophy; Torsades de pointes; Ventricular arrhythmias